ClosedHealth & Human Services
Rural Residency Planning and Development (RRPD) Program
Health Resources and Services AdministrationHRSA-24-022
Description
This notice announces the opportunity to apply for funding under the Health Resources and Services Administration (HRSA) Rural Residency Planning and Development (RRPD) Program. The purpose of this program is to improve and expand access to health care in rural areas by developing new, sustainable rural residency programs, including rural track programs (RTPs), that are accredited by the Accreditation Council for Graduate Medical Education (ACGME), to address the physician workforce shortages and challenges faced by rural communities. This program provides start-up funding to RRPD award recipients to create new rural residency programs that will be sustainable long-term through viable and stable funding mechanisms, such as, Medicare, Medicaid, and other public or private funding sources.
For the purposes of this notice of funding opportunity (NOFO), rural residency programs are accredited physician residency programs that train residents in rural training sites for greater than 50 percent of their total time in residency, and focus on producing physicians who will practice in rural communities. This includes programs that meet ACGME RTP Designation, including both new programs and permanent complement increases for new rural training site(s) for existing programs.
There are two pathways for this program: General Primary Care and High Need Specialty Pathway and Maternal Health and Obstetrics Pathway.
General Primary Care and High Need Specialty Pathway: This pathway supports the development of new rural residency training programs that focus on training to meet significant rural health needs. The eligible specialties in this pathway are family medicine, internal medicine, preventive medicine1, psychiatry, and general surgery.
Maternal Health and Obstetrics Pathway: This pathway supports the development of new rural residency programs with a focus on training to provide high quality, evidence-based maternity care and obstetrical services in rural areas. The eligible specialties in this pathway are obstetrics-gynecology and family medicine with enhanced obstetrical training. Enhanced obstetrical residency training must provide family medicine residents with extensive clinical experience in comprehensive maternity care, as outlined in ACGME’s program requirements, including dedicated training on labor and delivery and operative obstetrics. These programs must have faculty with clinical expertise to prepare family medicine residents for the independent practice of obstetrics in rural communities.
Award Ceiling
$750K
Total Funding
$11.3M
CFDA Number
93.155
Funding Instrument
Grant
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
November 14, 2023
Close Date
February 12, 2024
Posted Date
November 14, 2023
Eligible Applicant Types
County governmentsSpecial district governmentsIndependent school districtsFor profit organizations other than small businessesNative American tribal organizations (other than Federally recognized tribal governments)State governmentsSmall businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)City or township governmentsNative American tribal governments (Federally recognized)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Tags
HHS-HRSACFDA:93.155GrantHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left